279 related items for PubMed ID: 1541068
1. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K, Hewitson TD, Kincaid-Smith P.
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[Abstract] [Full Text] [Related]
2. A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN).
Auwardt R, Savige J, Wilson D.
Clin Nephrol; 1999 Jul; 52(1):1-4. PubMed ID: 10442488
[Abstract] [Full Text] [Related]
3. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM.
J Nephrol; 2005 Jul; 18(2):154-60. PubMed ID: 15931643
[Abstract] [Full Text] [Related]
4. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B.
Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
[Abstract] [Full Text] [Related]
5. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
Gang X, Ueki K, Kon S, Maeda M, Naruse T, Nojima Y.
Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
[Abstract] [Full Text] [Related]
6. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
Mitsuhashi H, Tsukada Y, Ono K, Yano S, Naruse T.
Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
[Abstract] [Full Text] [Related]
7. Urinary endothelin in glomerulonephritis patients with normal renal function.
Roccatello D, Mosso R, Ferro M, Polloni R, De Filippi PG, Quattrocchio G, Bancale E, Cesano G, Sena LM, Piccoli G.
Clin Nephrol; 1994 Jun; 41(6):323-30. PubMed ID: 8076434
[Abstract] [Full Text] [Related]
8. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
Rong ZH, Wang C, Hao J, Duan HJ.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
[Abstract] [Full Text] [Related]
9. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T, Ondrik Z, Abrahám G, Pokorny G, Túri S, Sonkodi S, Kemény E, Iványi B.
Orv Hetil; 2004 Jun 27; 145(26):1373-9. PubMed ID: 15384747
[Abstract] [Full Text] [Related]
10. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K, Kanmatsuse K.
Clin Nephrol; 2001 Apr 27; 55(4):269-74. PubMed ID: 11334311
[Abstract] [Full Text] [Related]
11. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
Am J Kidney Dis; 1997 Sep 27; 30(3):404-12. PubMed ID: 9292570
[Abstract] [Full Text] [Related]
12. Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy.
Nakamura T, Sugaya T, Ebihara I, Koide H.
Am J Nephrol; 2005 Sep 27; 25(5):447-50. PubMed ID: 16118482
[Abstract] [Full Text] [Related]
13. [Thin basement membrane disease in patients with asymptomatic hematuria and/or proteinuria: a clinicopathological study].
Ueno M.
Nihon Jinzo Gakkai Shi; 1991 Apr 27; 33(4):339-47. PubMed ID: 1875554
[Abstract] [Full Text] [Related]
14. Detection of activated platelets in urine by double immunofluorescence in children with IgA nephropathy.
Kamitsuji H, Nakajima M, Kawahara S, Nishimura T.
Nephron; 1998 Apr 27; 78(2):162-7. PubMed ID: 9496732
[Abstract] [Full Text] [Related]
15. A study of apoptosis in human glomerulonephritis as determined by in situ non-radioactive labelling of DNA strand breaks.
Wagrowska-Danilewicz M, Danilewicz M.
Acta Histochem; 1997 Aug 27; 99(3):257-66. PubMed ID: 9381909
[Abstract] [Full Text] [Related]
16. [Proliferative mesangial glomerulonephritis (PMGN) and IgA nephropathy (IgAGN). Immunohistochemical comparative analysis of cellular infiltrates and clinico-morphological correlations].
Wagrowska-Danilewicz M, Danilewicz M.
Przegl Lek; 1995 Aug 27; 52(7):347-53. PubMed ID: 8525002
[Abstract] [Full Text] [Related]
17. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
Davenport A, Maciver AG, Hall CL, MacKenzie JC.
Clin Nephrol; 1994 May 27; 41(5):271-6. PubMed ID: 8050206
[Abstract] [Full Text] [Related]
18. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
Kacprzyk F.
Pol Merkur Lekarski; 2003 Oct 27; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
[Abstract] [Full Text] [Related]
19. [A clinical and morphological study of thin basement membrane disease (TBMD)].
Sugiyama N.
Nihon Jinzo Gakkai Shi; 1994 Sep 27; 36(9):1010-20. PubMed ID: 7967172
[Abstract] [Full Text] [Related]
20. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.
Kobayashi S, Amano H, Terawaki H, Ogura M, Kawaguchi Y, Yokoo T.
BMC Nephrol; 2019 Aug 06; 20(1):306. PubMed ID: 31387546
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
